Table 2.
Comparison of sociodemographic variables and CV measures in ACHD patients based on reported disease-related relationship problems.
| Adverse impact on relationship | ||||
|---|---|---|---|---|
| No (N = 292) | Yes (N = 97) | Statistics | p-value | |
| Age (years) | 40.4 ± 11.8 | 38.3 ± 9.2 | U = 13157.0, Z = −1.048 | p = 0.295 |
| Female sex (N [%]) | 134 (46%) | 51 (53%) | χ2(1) = 1.305, φ = 0.058 | p = 0.253 |
| Number of thoracotomies | 1.4 ± 1.1 | 1.7 ± 1.3 | U = 11611.5, Z = −2.554 | p = 0.011 |
| Bethesda scale | χ2(2) = 13.979, φ = 0.190 | p < 0.001 | ||
| Bethesda I (N [%]) | 28 (10%) | 9 (9%) | ||
| Bethesda II (N [%]) | 108 (37%) | 17 (18%) | ||
| Bethesda III (N [%]) | 153 (53%) | 71 (73%) | ||
| NYHA classification | χ2(3) = 13.744, φ = 0.188 | p = 0.003 | ||
| NYHA I (N [%]) | 215 (74%) | 53 (55%) | ||
| NYHA II (N [%]) | 61 (21%) | 31 (32%) | ||
| NYHA III (N [%]) | 15 (5%) | 12 (12%) | ||
| NYHA IV (N [%]) | 1 (0.3%) | 1 (1%) | ||
| LVEF (%) | 56.3 ± 9.2 | 54.3 ± 8.8 | U = 9301.5, Z = −2.360 | p = 0.018 |
| NT-proBNP (ng/L) | 271.2 ± 416.0 | 320.1 ± 407.4 | U = 12,810,5, Z = −1.409 | p = 0.159 |
| Psychotropic drug (N [%]) | 9 (3%) | 12 (12%) | χ2(1) = 12.234, φ = 0.178 | p < 0.001 |
If not indicated otherwise mean ± standard deviation (SD) is depicted and asymptotic two-tailed p-values are shown. p ≤ 0.05 was considered statistically significant. LVEF, left ventricular ejection fraction; NYHA class, New York Heart Association Functional classification, NT-proBNP, N-terminal pro b-type natriuretic peptide.